It was reported here in March 2017 that BioTime, Inc. is conducting a Phase I/IIa clinical trial for OpRegen® for treatment of dry AMD. OpRegen is a retinal pigment epithelium (RPE) stem cell transplant therapy currently in development for the treatment of dry age-related macular degeneration (AMD) with geographic atrophy (GA). RPE cells are essential [Read More]
Tag: retinal transplantation
Cells From The Iris May Replace Retinal Photoreceptors
by Dan Roberts November 2001 An online publication of the December 2001 publication of Nature Neuroscience has reported that, with genetic manipulation, cells from the iris may be able to replace photoreceptor cells in the retina. In recent experiments, Dr. Masatoshi Haruta of Kyoto University and colleagues took iris cells from rat eyes, then introduced [Read More]